Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001851851 | SCV002297001 | likely pathogenic | not provided | 2023-12-28 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 46 of the INS protein (p.Arg46Gln). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with autosomal dominant maturity-onset diabetes of the young type (PMID: 18192540, 20226046, 28478482). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 13391). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. Experimental studies have shown that this missense change affects INS function (PMID: 20948967, 25423173). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. |
Clinical Genomics, |
RCV003445068 | SCV004174195 | uncertain significance | Diabetes mellitus, permanent neonatal 4 | criteria provided, single submitter | research | Potent mutations in the INS gene can cause early onset diabetes mellitus which is insulin dependent. May have poor response to sulfonylureas, mutations in this gene can cause beta cell destruction.Sufficient evidence is found to confer the association of this particular variant R46Q/ rs121908260 with permanent neonatal diabetes mellitus. | |
OMIM | RCV000014323 | SCV000034572 | pathogenic | Maturity-onset diabetes of the young type 10 | 2008-04-01 | no assertion criteria provided | literature only | |
Uni |
RCV000014323 | SCV000091150 | not provided | Maturity-onset diabetes of the young type 10 | no assertion provided | not provided |